Global programmatic experts Crimtan are delighted to welcome James Males to Crimtan as a Business Director based in London.
James Males is a veteran media and ad tech commercial person and has worked in the advertising industry for over 25 years. This experience has seen him work within many media disciplines including digital, DOOH, Gaming, TV, Radio and programmatic ad-technology.
Since 2013 James has dedicated his experience within the ad-tech Healthcare sector. He led the Commercial sales team for Adprime Health in EMEA. This followed by launching my own start-up business, a Co-founder of Vitality Ad Lab, the first programmatic platform for healthcare in Europe, which was later acquired by Pulsepoint in January 2018.
After the Pulsepoint acquisition he moved agency side to Havas Lynx, the pharma division of Havas, on a short-term contract. Then a move back into sales, to lead the commercial business for Tap Native in EMEA, a health and patient focused native ad platform.
James says of his appointment, “I am excited to be joining Crimtan at the inflection point that the industry is approaching a cookieless and programmatic world. It’s an exciting time for Crimtan with their proprietary ad technology which includes ActivID, and their slick dynamic creative solution." He adds, "there is a huge opportunity to continue to build Crimtan in the UK and EMEA regions as well as open new client verticals for health and pharmaceutical.”
Adform, the most powerful and safe media buying platform built for game changers, celebrates today…
Opti Digital, a premium ad revenue platform, unveils a new brand identity that embodies its…
In today’s Digest, Ireland pushes for Big Tech to vet financial ads, Warner Bros. Discovery…
We look at some of the key findings from this year’s All In Census (created…
This week, Google dominated headlines with bold moves across content, advertising, and AI, while lawmakers…
Intent IQ, a leading provider of identity resolution and data technology, today (May 8th, 2025)…